BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24823512)

  • 1. IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.
    Mehtap O; Atesoglu EB; Tarkun P; Hacihanefioglu A; Dolasik I; Musul MM
    J Postgrad Med; 2014; 60(2):141-4. PubMed ID: 24823512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of proinflammatory cytokine levels in sera from patients with Kaschin-Beck disease].
    Zhu CS; Feng QH; Yu YX; Wang DL; Chen M; Wang XY; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):84-5. PubMed ID: 16388753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of hepcidin in the anemia of multiple myeloma.
    Sharma S; Nemeth E; Chen YH; Goodnough J; Huston A; Roodman GD; Ganz T; Lichtenstein A
    Clin Cancer Res; 2008 Jun; 14(11):3262-7. PubMed ID: 18519751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
    Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
    Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome.
    Vitoratos N; Papadias C; Economou E; Makrakis E; Panoulis C; Creatsas G
    Mediators Inflamm; 2006; 2006(4):30485. PubMed ID: 17047289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in Alzheimer's disease and vascular dementia.
    Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
    Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes.
    Lu L; Zhang Q; Pu LJ; Xu XW; Zhang RY; Zhang JS; Hu J; Yang ZK; Lü AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
    Chin Med J (Engl); 2007 Mar; 120(6):479-84. PubMed ID: 17439741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma interleukin-1beta, -6, -8 and tumor necrosis factor-alpha as highly informative markers of pelvic inflammatory disease.
    Lee SA; Tsai HT; Ou HC; Han CP; Tee YT; Chen YC; Wu MT; Chou MC; Wang PH; Yang SF
    Clin Chem Lab Med; 2008; 46(7):997-1003. PubMed ID: 18624621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Shen JK; Dong LH; Qi H; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis.
    Bal A; Unlu E; Bahar G; Aydog E; Eksioglu E; Yorgancioglu R
    Clin Rheumatol; 2007 Feb; 26(2):211-5. PubMed ID: 16583185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.